Cargando…

The efficacy and safety of different bismuth agents in Helicobacter pylori first-line eradication: A multicenter, randomized, controlled clinical trial

BACKGROUND: The aim of this study was to evaluate the efficacy and safety of bismuth pectin capsules and bismuth pectin granules in the first-line quadruple treatment of Helicobacter pylori (H. pylori). METHODS: This study was a multicenter, randomized, open-labelled controlled clinical trial. Patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yaping, Zhang, Jian, Liu, Yuan, Zhang, Lifeng, Wang, Lu, Wang, Jie, Qi, Ying, Lv, Huanhuan, Liu, Juan, Huo, Lijuan, Wei, Xiaoguo, Shi, Yongquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678011/ https://www.ncbi.nlm.nih.gov/pubmed/34918639 http://dx.doi.org/10.1097/MD.0000000000027923

Ejemplares similares

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial
por: Su, Jing, et al.
Publicado: (2017)

The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: An open-label, single-arm pilot study
por: Zhang, Jian, et al.
Publicado: (2020)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis
por: Kuang, Sheng, et al.
Publicado: (2021)

Optimal treatment duration of bismuth-containing quadruple therapy in Helicobacter pylori infection: A retrospective study
por: Kim, Ji Yoon, et al.
Publicado: (2023)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial
por: Zhang, Di, et al.
Publicado: (2017)

Efficacy of Helicobacter pylori eradication therapy for treatment of functional dyspepsia: A protocol for systematic review and meta-analysis
por: Wang, Jue, et al.
Publicado: (2021)

Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis
por: Li, Renliang, et al.
Publicado: (2021)

Probiotics for Standard Triple Helicobacter pylori Eradication: A Randomized, Double-blind, Placebo-controlled Trial
por: Hauser, Goran, et al.
Publicado: (2015)

Characteristics and background mucosa status of early gastric cancer after Helicobacter pylori eradication: A narrative review
por: Wei, Yali, et al.
Publicado: (2022)

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation
por: Lee, Jung Wook, et al.
Publicado: (2021)

Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple Therapy
por: Dong, Fangyuan, et al.
Publicado: (2015)

A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2016)

Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study
por: Dore, Maria Pina, et al.
Publicado: (2018)

Comparative study of magnifying narrow-band imaging and conventional white light endoscopy in the diagnosis of Helicobacter pylori status after eradication therapy
por: Tahara, Tomomitsu, et al.
Publicado: (2019)

Association Between Early Helicobacter pylori Eradication and a Lower Risk of Recurrent Complicated Peptic Ulcers in End-Stage Renal Disease Patients
por: Chang, Shen-Shong, et al.
Publicado: (2015)

Halitosis and helicobacter pylori infection: A meta-analysis
por: Dou, Wenhuan, et al.
Publicado: (2016)

Helicobacter pylori prevalence in the Southwest of China: A protocol for systematic review
por: Wang, Rui, et al.
Publicado: (2020)

Local Immune Response in Helicobacter pylori Infection
por: Kivrak Salim, Derya, et al.
Publicado: (2016)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
por: Kim, Sung Eun, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and colorectal polyps
por: Basmaci, Nergis, et al.
Publicado: (2023)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
por: Wu, Meng-Chieh, et al.
Publicado: (2017)

Biosynthesis, structure and biological function of cholesterol glucoside in Helicobacter pylori: A review
por: Zhang, Lanchi, et al.
Publicado: (2023)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2019)

Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021)

Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: A meta-analysis of prospective epidemiologic studies
por: Liu, Hong, et al.
Publicado: (2017)

The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori
por: Lee, Seung Woo, et al.
Publicado: (2020)

Gastric microbiota in patients with Helicobacter pylori-negative gastric MALT lymphoma
por: Tanaka, Takahide, et al.
Publicado: (2021)

Association between helicobacter pylori infection and subclinical atherosclerosis: A systematic review and meta-analysis
por: Wang, Xianghong, et al.
Publicado: (2021)

Helicobacter pylori infection in women with Hashimoto thyroiditis: A case-control study
por: Shmuely, Haim, et al.
Publicado: (2016)

Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection
por: Choi, Yoon Jin, et al.
Publicado: (2016)

Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori
por: Wang, Junxian, et al.
Publicado: (2021)

Association between Helicobacter pylori infection and the risk of colorectal cancer: A systematic review and meta-analysis
por: Zuo, Yuling, et al.
Publicado: (2020)

Effect of licorice versus bismuth on eradication of Helicobacter pylori in patients with peptic ulcer disease
por: Momeni, Ali, et al.
Publicado: (2014)

The Comparison of Levofloxacin- and Clarithromycin-Based Bismuth Quadruple Therapy Regimens in Helicobacter pylori Eradication
por: Arj, Abbas, et al.
Publicado: (2020)

Efficacy of Clarithromycin Containing Bismuth–Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
por: Song, Zhiqiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ltonqn2qdfmb8t0drjgir80q8l